J Korean Med Assoc.  2015 Jul;58(7):655-658. 10.5124/jkma.2015.58.7.655.

Sublingual immunotherapeutics

• Lee DH

• KMID: 2064922
• DOI: http://doi.org/10.5124/jkma.2015.58.7.655

Abstract

Sublingual immunotherapy (SLIT) has been developed to prevent the severe adverse effects and anaphylaxis associated with subcutaneous immunotherapy (SCIT) in the early 1980s in European countries. Allergic Rhinitis and its Impact on Asthma (ARIA) expanded the indications for SLIT to include children in its 2001 guidelines. Many studies have proved that SLIT has therapeutic effects and successful immunologic tolerance in allergic patients, especially those with allergic rhinitis/conjunctivitis and asthma. SLIT is associated with a much lower frequency of anaphylaxis and generalized adverse effects and is easier to use than SCIT. The 2010 ARIA guidelines recommended SLIT for use in adults with seasonal and perennial allergic rhinitis (AR) and children with seasonal, but not perennial, AR. The US Agency for Healthcare Research and Quality states that the superiority of administration between SCIT and SLIT is not known, but moderate grade evidence from 2013 favors SCIT over SLIT for allergic nasal and/or eye symptom control. SLIT is a very safe way to correct Th2-mediated allergic diseases; however, more studies are needed to fully measure its therapeutic effects.

Keyword

Sublingual immunotherapy; Subcutaneous immunotherapy

MeSH Terms

Adult
Anaphylaxis
Asthma
Child
Health Services Research
Humans
Immunotherapy
Rhinitis
Seasons
Sublingual Immunotherapy

Reference

1. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol. 2003; 111:437–448.

2. Frew AJ. Sublingual immunotherapy. N Engl J Med. 2008; 358:2259–2264.

3. Noon L, Cantab BC. Prophylactic inoculation against hay fever. Lancet. 1911; 177:1572–1573.

4. Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet. 1911; 178:814–817.

5. Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, Potter PC, Bousquet PJ, Cox LS, Durham SR, Nelson HS, Passalacqua G, Ryan DP, Brozek JL, Compalati E, Dahl R, Delgado L, van Wijk RG, Gower RG, Ledford DK, Filho NR, Valovirta EJ, Yusuf OM, Zuberbier T, Akhanda W, Almarales RC, Ansotegui I, Bonifazi F, Ceuppens J, Chivato T, Dimova D, Dumitrascu D, Fontana L, Katelaris CH, Kaulsay R, Kuna P, Larenas-Linnemann D, Manoussakis M, Nekam K, Nunes C, O'Hehir R, Olaguibel JM, Onder NB, Park JW, Priftanji A, Puy R, Sarmiento L, Scadding G, Schmid-Grendelmeier P, Seberova E, Sepiashvili R, Sole D, Togias A, Tomino C, Toskala E, Van Beever H, Vieths S. Sub-lingual immunotherapy: World Allergy Organization position paper 2009. Allergy. 2009; 64:Suppl 91. 1–59.

6. Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S, Bousquet J, Calderon M, Compalati E, Durham SR, van Wijk RG, Larenas-Linnemann D, Nelson H, Passalacqua G, Pfaar O, Rosario N, Ryan D, Rosenwasser L, Schmid-Grendelmeier P, Senna G, Valovirta E, Van Bever H, Vichyanond P, Wahn U, Yusuf O. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J. 2014; 7:6.

7. Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy. 2006; 61:151–165.

8. Steinke JW, Lawrence MG. T-cell biology in immunotherapy. Ann Allergy Asthma Immunol. 2014; 112:195–199.

9. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014; 133:621–631.

10. Van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Sollner S, Akdis DG, Ruckert B, Akdis CA, Akdis M. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 2013; 131:1204–1212.

11. Soyer OU, Akdis M, Ring J, Behrendt H, Crameri R, Lauener R, Akdis CA. Mechanisms of peripheral tolerance to allergens. Allergy. 2013; 68:161–170.

12. Dunsky EH, Goldstein MF, Dvorin DJ, Belecanech GA. Anaphylaxis to sublingual immunotherapy. Allergy. 2006; 61:1235.

13. Vovolis V, Kalogiros L, Mitsias D, Galani M, Sifnaios E. Repeated severe anaphylactic reactions to sublingual immunotherapy. Allergy. 2012; 67:Suppl 96. 409–410.

14. Park H. A case of anaphylaxis after the first dose of sublingual immunotherapy with house dust mite. Allergy. 2011; 66:Suppl 94. 625–626.

15. De Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy. 2009; 64:963–964.

16. Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy. 2008; 63:374.

17. Eifan AO, Keles S, Bahceciler NN, Barlan IB. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy. 2007; 62:567–568.

18. Van Dyken AM, Smith PK, Fox TL. Clinical case of anaphylaxis with sublingual immunotherapy: house dust mite allergen. J Allergy Clin Immunol Pract. 2014; 2:485–486.

19. Scala G, Ciccarelli A, Calabro C. Adverse reaction to sublingual Parietaria vaccine following an ultra-rush induction. Eur Ann Allergy Clin Immunol. 2014; 46:116–118.

20. Agency for Healthcare Research and Quality. Allergen-specific immunotherapy for the treatment of allergic rhinoconjunctivitis and/or asthma: comparative effectiveness review [Internet]. Rockville: Agency for Healthcare Research and Quality;2013. cited 2015 Jun 26. Available from: http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?productid=1427&pageaction=displayproduct.

21. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ. Global Allergy and Asthma European Network. Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010; 126:466–476.

22. Okubo K, Kurono Y, Fujieda S, Ogino S, Uchio E, Odajima H, Takenaka H. Japanese Society of Allergology. Japanese Guideline for Allergic Rhinitis 2014. Allergol Int. 2014; 63:357–375.